Rheumatology swapped the scalpel for the pill around the year 2000
Rheumatologists handle more than a hundred inflammatory conditions, from gout to lupus, many now understood as the immune system misfiring. In 1970 a Norwegian estimate held that at least half of rheumatic patients needed surgery. Three decades later, new biological drugs had made operations the exception and medication the backbone of care.
The name comes from the Greek rheuma, a flowing current. The specialty covers inflammation in bones, muscles, joints and internal organs, and because so many of these illnesses turn out to be immune disorders, it overlaps heavily with immunology. In the United States, becoming a rheumatologist takes four years of college, four of medical school, three of internal medicine residency and then two or three more of fellowship.
Diagnosis blends hands-on examination with the laboratory. Schober's test gauges how far the lower back bends; screening, general and regional musculoskeletal exams range from quick checks to detailed assessments of inflamed joints. Blood markers such as rheumatoid factor, anti-CCP antibodies and antinuclear antibodies help, and fluid drawn from a swollen joint can distinguish infection from gout.
Surgery once had a central role. Rheumasurgery grew out of cooperation between rheumatologists and orthopaedic surgeons in Heinola, Finland, in the 1950s, and a European society devoted to it was founded in 1979. Operations fell into two kinds: early removal of inflamed joint lining to halt spread, and corrective work after damage, such as joint replacement or fusion. From the 2000s, biopharmaceuticals that block TNF-alpha, certain interleukins or the JAK-STAT pathway entered standard care, alongside older disease-modifying drugs such as methotrexate, and are counted among the field's most important advances.
The field keeps changing. A UK survey of 218 rheumatology professionals between 2025 and 2026 found around 40 percent already using AI daily or weekly, most often to look up facts, and 86 percent expected it to reshape practice within five years, though 70 percent worried about data security and liability. Paediatric rheumatology faces a different problem: slow recognition of the subspecialty has left a global shortage of doctors trained to treat children.
Source: Rheumatology
